August 4, 2014
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on Drugs, an advisory panel to the health minister, on August 1 recommended approval of MSD’s insomnia treatment suvorexant. Suvorexant, which is currently under review in the US, has not...read more